Transgelin 2 Antibody - #DF12053
(3)
(7)
| Product: | Transgelin 2 Antibody |
| Catalog: | DF12053 |
| Description: | Rabbit polyclonal antibody to Transgelin 2 |
| Application: | WB IHC |
| Reactivity: | Human, Mouse, Rat |
| Prediction: | Pig, Zebrafish, Bovine, Horse, Sheep, Rabbit, Dog |
| Mol.Wt.: | 22 kDa; 22kD(Calculated). |
| Uniprot: | P37802 |
| RRID: | AB_2844858 |
Related Downloads
Protocols
Product Info
Source:
Rabbit
Application:
WB 1:500-1:2000, IHC 1:50-1:200
*The optimal dilutions should be determined by the end user.
*Tips:
*The optimal dilutions should be determined by the end user.
*Tips:
WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.
Reactivity:
Human,Mouse,Rat
Prediction:
Pig(100%), Zebrafish(82%), Bovine(100%), Horse(100%), Sheep(100%), Rabbit(100%), Dog(100%)
Clonality:
Polyclonal
Specificity:
Transgelin 2 Antibody detects endogenous levels of total Transgelin 2.
RRID:
AB_2844858
Cite Format: Affinity Biosciences Cat# DF12053, RRID:AB_2844858.
Cite Format: Affinity Biosciences Cat# DF12053, RRID:AB_2844858.
Conjugate:
Unconjugated.
Purification:
The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).
Storage:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
Alias:
Fold/Unfold
CDABP0035; epididymis tissue protein Li 7e; HA1756; KIAA0120; SM22-alpha homolog; TAGL2_HUMAN; Tagln2; Transgelin-2;
Immunogens
Immunogen:
Uniprot:
Gene(ID):
Expression:
Sequence:
- P37802 TAGL2_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MANRGPAYGLSREVQQKIEKQYDADLEQILIQWITTQCRKDVGRPQPGRENFQNWLKDGTVLCELINALYPEGQAPVKKIQASTMAFKQMEQISQFLQAAERYGINTTDIFQTVDLWEGKNMACVQRTLMNLGGLAVARDDGLFSGDPNWFPKKSKENPRNFSDNQLQEGKNVIGLQMGTNRGASQAGMTGYGMPRQIL
Predictions
Predictions:
Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.
Species
Results
Score
Pig
100
Horse
100
Bovine
100
Sheep
100
Dog
100
Rabbit
100
Zebrafish
82
Xenopus
75
Chicken
0
Model Confidence:
High(score>80) Medium(80>score>50) Low(score<50) No confidence
High(score>80) Medium(80>score>50) Low(score<50) No confidence
PTMs - P37802 As Substrate
| Site | PTM Type | Enzyme | Source |
|---|---|---|---|
| A2 | Acetylation | Uniprot | |
| R4 | Methylation | Uniprot | |
| Y8 | Phosphorylation | Uniprot | |
| S11 | Phosphorylation | P17252 (PRKCA) | Uniprot |
| K17 | Acetylation | Uniprot | |
| K17 | Ubiquitination | Uniprot | |
| K20 | Acetylation | Uniprot | |
| K20 | Ubiquitination | Uniprot | |
| K40 | Ubiquitination | Uniprot | |
| K57 | Sumoylation | Uniprot | |
| T60 | Phosphorylation | Uniprot | |
| K78 | Acetylation | Uniprot | |
| K78 | Ubiquitination | Uniprot | |
| K79 | Sumoylation | Uniprot | |
| K79 | Ubiquitination | Uniprot | |
| S83 | Phosphorylation | O94921 (CDK14) | Uniprot |
| T84 | Phosphorylation | Uniprot | |
| K88 | Acetylation | Uniprot | |
| K88 | Ubiquitination | Uniprot | |
| S94 | Phosphorylation | Uniprot | |
| T128 | Phosphorylation | Uniprot | |
| R139 | Methylation | Uniprot | |
| S145 | Phosphorylation | Uniprot | |
| K153 | Acetylation | Uniprot | |
| K153 | Ubiquitination | Uniprot | |
| K154 | Ubiquitination | Uniprot | |
| K156 | Ubiquitination | Uniprot | |
| S163 | Phosphorylation | O94921 (CDK14) , P17612 (PRKACA) | Uniprot |
| K171 | Acetylation | Uniprot | |
| K171 | Sumoylation | Uniprot | |
| K171 | Ubiquitination | Uniprot | |
| T180 | Phosphorylation | P17252 (PRKCA) | Uniprot |
| R182 | Methylation | Uniprot | |
| S185 | Phosphorylation | P17252 (PRKCA) | Uniprot |
| T190 | Phosphorylation | Uniprot | |
| Y192 | Phosphorylation | Uniprot | |
| R196 | Methylation | Uniprot |
Research Backgrounds
Tissue Specificity:
Expressed in epididymis (at protein level).
Family&Domains:
Belongs to the calponin family.
References
1). TAGLN2 induces resistance signature ISGs by activating AKT-YBX1 signal with dual pathways and mediates the IFN-related DNA damage resistance in gastric cancer. Cell death & disease, 2024
(PubMed: 39168971)
[IF=8.1]
Application: IHC Species: Human Sample: gastric cancer (GC) tissue
Fig. 1. Aberrantly upregulated expression of TAGLN2 results in the induction of ISGs. A Aberrantly upregulated TAGLN2 protein expression was assessed by IHC analysis in gastric cancer (GC) tissue microarray (TMA) chips containing 75 tumor tissues and their paired normal counterparts. B Cellular TAGLN2 expression in tumor tissues vs. paired normal counterparts was evaluated in the membrane, cytoplasm and nucleus. Distant metastases (M), T stage and overall cancer stage (Stage I~IV) were significantly correlated with TAGLN2 expression in the cytoplasm. C Representative IHC images show that abnormal TAGLN2 expression level increases as GC progresses (Stage I~IV). The results were obtained by multiplying the PP by the IS (immunoreactive score = PP × IS). *P
2). Comparative proteomics identify HSP90A, STIP1 and TAGLN‑2 in serum extracellular vesicles as potential circulating biomarkers for human adenomyosis. Experimental and Therapeutic Medicine, 2022
(PubMed: 35495589)
[IF=2.4]
Application: WB Species: human Sample: T‑AMEVs and B‑AMEVs
Figure 4. | HSP90A, STIP1 and TAGLN‑2 are expressed in B‑AMEVs and T‑AMEVs. (D and E) HSP90A, STIP1 and TAGLN‑2 were present in T‑AMEVs and B‑AMEVs from patients with adenomyosis,but not in those of patients in the control group.
3). Overexpression of TAGLN2 regulated by non-coding RNAs refering to poor prognosis and tumor immune cell infiltration in hepatocellular carcinoma. Research Square, 2023
Application: WB Species: Human Sample: HCC tissues
Figure 10. Validation results of TAGLN2 expression in HCC. (a) qRT-PCR analysis of TAGLN2 mRNA expression in 20 pairs of HCC tissues and adjacent non-tumor tissues. (b) Western blot detection of TAGLN2 protein expression and relative quantification in the mean values of three HCC tumor tissues and three neighboring tissues showed elevated TAGLN2 protein expression in HCC tumor tissues. (c) IHC analysis of TAGLN2 stained significantly darker in tumor tissues and had higher protein expression levels than adjacent tissues. (*P < 0.05, **P< 0.01, ***P < 0.001).
Restrictive clause
Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.
For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.